Varenicline for smoking cessation in hospitalized patients with acute coronary syndrome

…, A Clarke, D Cassavar, D Dion, H Haught… - Circulation, 2016 - Am Heart Assoc
Background— Less than one-third of smokers hospitalized with an acute coronary syndrome
(ACS) remain abstinent following discharge. We assessed whether varenicline, begun in-…

Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide …

AJ Burger, U Elkayam, MT Neibaur, H Haught… - The American journal of …, 2001 - Elsevier
Ventricular arrhythmias are common in patients with congestive heart failure (CHF) and may
be exacerbated by positive inotropic therapy. Because human B-type natriuretic peptide (…

Smoking abstinence 1 year after acute coronary syndrome: follow-up from a randomized controlled trial of varenicline in patients admitted to hospital

…, N Srivastava, A Clarke, D Cassavar, D Dion, H Haught… - Cmaj, 2018 - Can Med Assoc
BACKGROUND: Patients who continue to smoke after acute coronary syndrome are at
increased risk of reinfarction and death. We previously found use of varenicline to increase …

[HTML][HTML] Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure

…, C Liang, M Neibaur, WH Haught… - … England Journal of …, 2000 - Mass Medical Soc
Background Intravenous infusion of nesiritide, a brain (B-type) natriuretic peptide, has
beneficial hemodynamic effects in patients with decompensated congestive heart failure. We …

Torsemide vs furosemide among patients with new-onset vs worsening chronic heart failure: a substudy of the TRANSFORM-HF randomized clinical trial

…, A Chen, D Wojdyla, J Vilaro, H Haught… - JAMA …, 2024 - jamanetwork.com
Importance Differences in clinical profiles, outcomes, and diuretic treatment effects may
exist between patients with de novo heart failure (HF) and worsening chronic HF (WHF). …

Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: the TRANSFORM-HF randomized clinical trial

…, YA Lev, P William, AL Eberly, SS Gottleib, WH Haught… - JAMA, 2023 - jamanetwork.com
Importance Although furosemide is the most commonly used loop diuretic in patients with
heart failure, some studies suggest a potential benefit for torsemide. Objective To determine …

Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction: An International …

…, H Krasa, CA Zimmer, G Frivold, WH Haught… - Journal of the American …, 2008 - jacc.org
Objectives : This study sought to assess the acute hemodynamic effect of vasopressin V 2
receptor antagonism. Background : In decompensated heart failure (HF), tolvaptan, a …

Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and …

L Chen, WH Haught, B Yang, TGP Saldeen… - Journal of the American …, 1997 - jacc.org
Objectives. We sought to document the common mechanisms of the antiatherogenic effects
of the cholesterol-lowering hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase …

Short-term effects of tolvaptan in patients with acute heart failure and volume overload

…, R Dhingra, FV Mody, H Eisen, WH Haught… - Journal of the American …, 2017 - jacc.org
Background : In patients with acute heart failure (AHF), dyspnea relief is the most immediate
goal. Renal dysfunction, diuretic resistance, and hyponatremia represent treatment …

Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease

WH Haught, M Mansour, R Rothlein, TK Kishimoto… - American heart …, 1996 - Elsevier
Atherosclerosis is increasingly thought to be a chronic inflammatory disease. Inflammation
requires transmigration of leukocytes from the circulation to the tissues. Adhesion of …